Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase IIIb, Multicenter, Randomized, Double Masked, SHAM Injection, Controlled Study of the Efficacy and Safety of Ranibizumab in Subjects with Subfoveal Choroidal Neovascularization (CNV) with or without Classic CNV Secondary to Age Related Macular Degeneration
ranibizumab
FVF2598G
NCT00056836
Neovascular Age-related Macular Degeneration
Phase 3
 
December 2015

Powered by ideaPoint, Inc.